Improving Outcomes and Lowering the Cost of Care

 

The healthcare industry evolving, with pressure to improve patient outcomes, while simultaneously lowering the cost of care has become a pertinent issue. A 2020 survey found that U.S. healthcare spending is projected to exceed $6 trillion by 2028, highlighting the need for efficient solutions that deliver high-quality care without the hefty price tag. But how can providers achieve this delicate balance? Part of that answer lies in leveraging data and innovative technologies.

What does it take for healthcare organizations to provide value, remain competitive, and ultimately, improve patient outcomes while lowering costs?

On this episode of “Highway to Health,” host David Kemp sat down with Kevin Freeman, Chief Commercial Officer at Health Catalyst, a company at the forefront of outcomes improvement in healthcare. Together, they explore the strategies, technologies, and mindsets healthcare leaders can adopt to drive progress in these challenging times.

Several takeaways from the episode explored:

  • Prioritizing mental and physical health is crucial for healthcare leaders to maintain peak performance and leadership success.
  • Why data-driven decision-making is essential, but organizations must also develop data literacy to effectively apply insights for improvement.
  • How long-term partnerships are built on value delivery. It’s not just about liking a vendor; and that providers need measurable outcomes to sustain these relationships.

Kevin Freeman is the Chief Commercial Officer at Health Catalyst, and has over 15 years of experience in healthcare data and outcomes improvement. His work focuses on helping healthcare organizations make informed decisions through data, driving value and transformation across the sector. Health Catalyst has developed more than 300 use cases of outcome improvements, making them a trusted partner in healthcare innovation.

Article by Alexandra Simon.

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…